United States: CMS Issues Final Mandatory Episode Payment Models For Cardiac And Orthopedic Cases, Plus New Cardiac Rehabilitation Incentive Payment Model And CJR Program Refinements

In the waning days of the Obama Administration, the Centers for Medicare & Medicaid Services (CMS) has unveiled a lengthy and complex final rule to establish mandatory Medicare bundled payment programs for acute myocardial infarction (AMI), coronary artery bypass graft (CABG), and surgical hip/femur fracture treatment (SHFFT) procedures furnished in designated geographic areas. The rule also includes provisions to promote the use of cardiac rehabilitation services, refine current Comprehensive Care for Joint Replacement Model (CJR) rules, and integrate bundled payment programs into the new physician Quality Payment Program. The 1,606-page advance version of the rule was released on December 20, 2016; the official version is scheduled to be published January 3, 2017.

Note that President-elect Donald Trump's designee for Secretary of Health and Human Services, Rep. Tom Price, M.D., has been highly critical of the proposed version of the rule published in August 2016, and has called on the CMS Center for Medicare and Medicaid Innovation (CMMI) to "stop experimenting with Americans' health, and cease all current and future planned mandatory initiatives within the CMMI." It is therefore uncertain whether all provisions of the final rule will actually be implemented as CMS currently envisions. Nevertheless, impacted providers need to be prepared for potentially significant changes.

Mandatory Episode Payment Models for Cardiac Care, Hip/Femur Fractures

The final rule establishes new "episode payment models" (EPMs) that seek to "advance CMS' goal of improving the efficiency and quality of care for Medicare beneficiaries and encourage hospitals, physicians, and post-acute care providers to work together to improve the coordination of care from the initial hospitalization through recovery." CMS estimates that the EPMs will save $159 million during the duration of the program (July 1, 2017 through December 31, 2021).

CMS will "test" the EPMs beginning July 1, 2017 and ending December 31, 2021. CMS has selected 98 metropolitan statistical areas (MSAs) for the CABG and AMI EPMs, and will implement the SHFFT model in the same 67 MSAs where the CJR program is already underway. Acute care hospitals in these areas will participate in the models if they are paid under the Inpatient Prospective Payment System (IPPS) and are not concurrently participating in Models 2, 3, or 4 of the Innovation Center's Bundled Payment for Care Improvement (BPCI) initiative for AMI, CABG, or SHFFT episodes. CMS estimates that approximately 1,120 hospitals will participate in the AMI and CABG models, and 860 hospitals will participate in the SHFFT model.

Under the final rule, an AMI, CABG, or SHFFT model episode will begin with an inpatient admission to an "anchor hospital" for the following specified Medicare Severity-Diagnosis Related Groups (MS-DRG):

AMI Model: AMI MS-DRGs 280-282 and those Percutaneous Coronary Intervention (PCI) MS-DRGs (246-251) with an ICD-10-CM diagnosis code of AMI

CABG Model: MS-DRGs 231-236

SHFFT Model: MS-DRGs 480-482

The episode will end 90 days after the date of discharge. The episode will include the inpatient stay and almost all related care covered under Medicare Parts A and B within the 90 days after discharge, including hospital care, post-acute care, and physician services, with very limited exceptions. Note, however, that CMS will continue to pay hospitals and other providers and suppliers according to the usual Medicare fee-for-service (FFS) rules.

As under the current CJR program, the acute care hospital will be the "episode initiator" and bear financial risk for the quality and cost of EPM care. At the completion of an EPM model performance year (PY), CMS will compare (1) actual Medicare claims data for Medicare Parts A and B services furnished to beneficiaries during the episode, to (2) a hospital's quality-adjusted target price based on historical data with various adjustments and discount factors to reflect savings to Medicare. The target price initially will be based on a blend of hospital-specific and regional historical data, gradually transitioning to only regional pricing. Hospitals that deliver care for less than the quality-adjusted target price and meet applicable quality standards will be eligible for a "reconciliation payment"; hospitals with costs that exceed the quality-adjusted target price will be required to repay Medicare after a phase-in period.

A number of factors are considered in determining reconciliation and repayment amounts, including stop-loss and stop-gain limits intended to "both protect hospitals from excess financial risk offset while limiting gains proportional to the potential downside risk."

The final stop-gain limits are as follows:

PY Calendar Year EPM Episodes Included Stop Gain Limit
1 2017 EPM episodes that start on or after July 1, 2017 and end on or before December 31, 2017 Up to 5% of quality-adjusted target price
2 2018 EPM episodes that end between January 1, 2018 and December 31, 2018, inclusive Up to 5% of quality-adjusted target price
3 2019 EPM episodes that end between January 1, 2019 and December 31, 2019, inclusive Up to 5% of quality-adjusted target price
4 2020 EPM episodes that end between January 1, 2020 and December 31, 2020, inclusive Up to 10% of quality-adjusted target price
5 2021 EPM episodes that end between January 1, 2021 and December 31, 2021, inclusive Up to 20% of quality-adjusted target price

In the final rule, CMS is delaying the requirement to assume downside risk by 9 months; episodes ending on or after January 1, 2019 must assume downside risk. CMS is, however, allowing participants to voluntarily elect downside risk for episodes ending on or after January 1, 2018 in order to qualify as an Advanced Alternative Payment Model (APM) under the separate CMS Quality Payment Program (assuming all other conditions are met). The following table summarizes the final stop-loss thresholds and discount percentages by performance year (with lower thresholds for certain rural hospitals):

PY 1 PY 2 PY 3 PY 4 PY 5
Downside Risk (DR) for All Participants– DR effective for episodes ending on or after 1/1/2019 (anchor discharges occurring on or after 10/4/2018)
Stop-loss threshold n/a as no downside risk in PY1 and PY2 without election of voluntary downside risk for PY2 5% 10% 20%
Stop loss threshold for certain hospitals* 3% 5% 5%
Discount percentage (range) for Repayment, Depending on Quality Category 0.5%-2.0% 0.5%-2.0% 1.5%-3.0%
Voluntary Downside Risk – DR effective for episodes ending on or after 1/1/2018 (anchor discharges occurring on or after 10/4/2017)
Stop-loss threshold n/a as no downside risk in PY1 5% 5% 10% 20%
Stop loss threshold for certain hospitals* 3% 3% 5% 5%
Discount percentage (range) for Repayment, Depending on Quality Category 0.5%-2.0% 0.5%-2.0% 0.5%-2.0% 1.5%-3.0%

*Including rural and sole-community hospitals, rural referral centers, Medicare Dependent Hospitals and hospitals determined to be EPM volume protection hospitals within an EPM.

CMS anticipates that EPM hospitals will enter into financial arrangements that allow EPM participants to share financial risk with EPM "collaborators" (e.g., gainsharing). The final rule includes the following entities as permissible EPM collaborators: accountable care organizations; skilled nursing facilities (SNFs); home health agencies; long-term care hospitals; inpatient rehabilitation facilities; physicians; nonphysician practitioners; therapists in private practice; comprehensive outpatient rehabilitation facilities; providers of outpatient therapy services; physician group practices; hospitals; critical access hospitals; non-physician practitioner group practices, and therapy group practices. Any such financial arrangements must meet extensive standards set forth in the rule.

Under the final rule, CMS is waiving certain current Medicare rules to promote flexibility, including the three-day inpatient hospital stay requirement prior to a covered SNF stay (in limited circumstances) and certain telehealth restrictions. CMS is not waiving fraud and abuse authorities under the final rule, but CMS states that the HHS Office of the Inspector General (OIG) and CMS will jointly issue waivers of certain fraud and abuse laws for purposes of testing these models.

Cardiac Rehabilitation Model

CMS is also finalizing a new Cardiac Rehabilitation (CR) incentive payment model to test the use of CR and intensive cardiac rehabilitation (ICR) services for beneficiaries hospitalized for treatment of an AMI or CABG for 90 days post-hospital discharge, where the beneficiary's overall care is paid under either an EPM or the Medicare FFS program. CR incentive payments will be available to hospital participants in 45 geographic areas that were selected for the CABG and AMI EPMs and 45 geographic areas that were not selected for the EPM program, and it will cover the same period as the cardiac care EPMs.

Under this model, CMS will make standard Medicare payments to providers for CR/ICR services (HCPCS codes 93797, 93798, G0422, and G0423), with an additional retrospective payment to participant hospitals based on total CR service use by beneficiaries attributed to the hospital (subject to Medicare coverage limits). CMS will make an initial payment of $25 per CR/ICR service for each of the first 11 CR/ICR services paid for by Medicare during the care period; after 11 services, the per-service payment increases to $175.

CMS estimates that 1,320 hospitals will participate in the CR Incentive Payment Model, and that the model's impact on Medicare spending could range between $29 million in net Medicare costs and $32 million in net Medicare savings from July 2017 through December 2024, depending on the change in utilization of CR/ICR services.

Changes to CJR Program

The final rule adopts numerous changes to CJR program rules, including modifications to promote consistency with other EPM policies. Among many other things, the final rule: modifies the calculation of quality adjusted target prices for Performance Years 3, 4, and 5 to include reconciliation and repayment amounts; revises beneficiary inclusion criteria; adopts changes to the reconciliation process; clarifies determinations that may be appealed; streamlines beneficiary notification requirements; expands the permissible types of CJR collaborators; revises SNF waiver policies; adds to the list of permissible CJR collaborators; and modifies the terms for CJR sharing arrangements.

Medicare ACO Track 1+ Model

Separate from the final rule, CMS announced a new Medicare ACO Track 1+ Model incorporating more limited downside risk than in Tracks 2 or 3 of the Medicare Shared Savings Program. This model, which will begin in 2018, will qualify as an Advanced APM for purposes of the Quality Payment Program.

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions